NON CANONICAL NFKB ACTIVATION PROMOTES EXPRESSION OF CCL21 IN PODOCYTES

被引：0
|
作者：
Sanchez-Nino, Maria D. [1 ]
Ortiz, Alberto [1 ]
机构：
[1] IIS FJD, Nephrol, Madrid, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv166.11
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP023
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells
    Yasuda, T
    Nakano, H
    Yoshida, H
    Kakiuchi, T
    IMMUNOLOGY 2004: CYTOKINE NETWORK, REGULATORY CELLS, SIGNALING, AND APOPTOSIS, 2004, : 525 - 528
  • [42] Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis -: Possible pathogenic role in plaque destabilization
    Damas, Jan K.
    Smith, Camilla
    Oie, Erik
    Fevang, Borre
    Halvorsen, Bente
    Wæhre, Torgun
    Boullier, Agnes
    Breland, Unni
    Yndestad, Arne
    Ovchinnikova, Olga
    Robertson, Anna-Karin L.
    Sandberg, Wiggo J.
    Kjekshus, John
    Tasken, Kjetil
    Froland, Stig S.
    Gullestad, Lars
    Hansson, Goran K.
    Quehenberger, Oswald
    Aukrust, Pal
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) : 614 - 620
  • [43] A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21
    Martin, AP
    Coronel, EC
    Sano, G
    Chen, SC
    Vassileva, G
    Canasto-Chibuque, C
    Sedgwick, JD
    Frenette, PS
    Lipp, M
    Furtado, GC
    Lira, SA
    JOURNAL OF IMMUNOLOGY, 2004, 173 (08): : 4791 - 4798
  • [44] Low molecular weight heparins inhibit CCL21-induced T-cell migration: Targeting the endothelial expression of CCL21 in autoimmune diseases.
    Christopherson, KW
    Campbell, JJ
    Travers, JB
    Hood, AF
    Ramsey, HC
    Hromas, RA
    BLOOD, 2001, 98 (11) : 233A - 233A
  • [45] Quantitative analysis of CCL21, CCL19, and CCR7 mRNA expression in primary and metastatic cutaneous malignant melanoma
    Monteagudo, Carlos
    Ramos, David
    Alonso, Vicent
    López-Guerrero, José Antonio
    Jorda, Esperanza
    Llombart-Bosch, Antonio
    Pellin, Antonio
    MODERN PATHOLOGY, 2006, 19 : 44 - 44
  • [46] Transgenic over-expression of the CC chemokine CCL21 disrupts T-cell migration.
    Christopherson, KW
    Campbell, JJ
    Hromas, RA
    BLOOD, 2001, 98 (11) : 236A - 236A
  • [47] CXCL13 and CCL21 expression in Sjogren's syndrome (Ss): An immunohistochemical and structural analysis.
    Barone, F
    Manzo, A
    Caporali, R
    Montecucco, M
    Valesini, G
    Pitzalis, C
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S563 - S563
  • [48] Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis
    Bielecki, Bartosz
    Jatczak-Pawlik, Izabela
    Wolinski, Pawel
    Bednarek, Andrzej
    Glabinski, Andrzej
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (05) : 367 - 376
  • [49] Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules
    Carlsen, HS
    Haraldsen, G
    Brandtzaeg, P
    Baekkevold, ES
    BLOOD, 2005, 106 (02) : 444 - 446
  • [50] Oncostatin M increases CCL21 expression by human primary endothelial cells in vitro and in marine skin in vivo
    Cardones, AR
    Sugaya, M
    Blauvelt, A
    Hwang, ST
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A2 - A2
12345